The role of type I interferons and other cytokines in dermatomyositis
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective studyJournal of the American Academy of Dermatology, 2011
- Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon productionClinical Immunology, 2010
- Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligandRheumatology, 2010
- Both RIG-I and MDA5 RNA Helicases Contribute to the Induction of Alpha/Beta Interferon in Measles Virus-Infected Human CellsJournal of Virology, 2010
- Interferon‐stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophyAnnals of Neurology, 2010
- Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5Journal of Experimental Medicine, 2008
- Type I interferon–inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositisArthritis & Rheumatism, 2007
- 5'-Triphosphate RNA Is the Ligand for RIG-IScience, 2006
- MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: Association with muscle involvementClinical Immunology, 2006
- The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 2004